What describes the hapten-carrier effect in vaccines?

• A. Small molecules (haptens) become immunogenic when conjugated to a carrier protein.
• B. Haptens bind directly to T cell receptors without carriers.
• C. Carriers inhibit hapten recognition.
• D. Haptens are always immunogenic by themselves.

Answer: (A)

The hapten-carrier effect hinges on a simple idea: tiny molecules called haptens aren’t immunogenic on their own because they’re too small to elicit a robust B and T cell response. When a hapten is covalently attached to a larger carrier protein, B cells that bind the hapten take up the whole conjugate and present carrier-derived peptides to helper T cells. This T cell help provides the necessary signals for the B cell to proliferate, class-switch, and improve antibody affinity, producing a strong, specific response against the hapten.

So the best description is that small molecules become immunogenic when linked to a carrier protein, enabling the immune system to mount a targeted response. In contrast, haptens don’t bind T cell receptors directly without a carrier, carriers don’t inhibit hapten recognition but rather enable it, and haptens are not always immunogenic by themselves.